Synthesis and Biological Evaluation of Cyclobutane-Based ß3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy. (2023)
Attributed to:
Design, synthesis and applications of chiral cyclobutanes
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers15164023
PubMed Identifier: 37627051
Publication URI: http://europepmc.org/abstract/MED/37627051
Type: Journal Article/Review
Volume: 15
Parent Publication: Cancers
Issue: 16
ISSN: 2072-6694